Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Breast Cancer Research and Treatment
|
December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Research Square
|
October 4, 2023
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade
Geoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Nature Communications
|
December 27, 2022
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression
Lufei Sui, Suming Wang, Debolina Ganguly, et al.
Nature Communications
|
January 9, 2023
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, et al.
Cancer Discovery
|
October 2, 2025
Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase
Yang Bai, Albert S Agustinus, Shira Yomtoubian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2020
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan, Amy Willis, Naomi Kornhauser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan, Amy Willis, Naomi Kornhauser, et al.
Nature Communications
|
January 3, 2024
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Nature Communications
|
December 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Breast Cancer Research and Treatment
|
December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Research Square
|
October 4, 2023
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade
Geoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Nature Communications
|
December 27, 2022
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression
Lufei Sui, Suming Wang, Debolina Ganguly, et al.
Nature Communications
|
January 9, 2023
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, et al.
Cancer Discovery
|
October 2, 2025
Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase
Yang Bai, Albert S Agustinus, Shira Yomtoubian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2020
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan, Amy Willis, Naomi Kornhauser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Nancy Chan, Amy Willis, Naomi Kornhauser, et al.
Nature Communications
|
January 3, 2024
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Nature Communications
|
December 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Page
of 11